AC
AGN

Argentiere Capital’s Allergan plc AGN Stock Holding History

Argentiere Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-26,000
Closed -$3.81M – 36
2019
Q1 		$3.81M Sell
26,000
-9,000
-26% -$1.3M 1.65% 26
2018
Q4 		$4.68M Buy
+35,000
New +$5.74M 1.46% 11
2018
Q3 		– Sell
-18,000
Closed -$3M – 100
2018
Q2 		$3M Buy
+18,000
New +$2.89M 1.16% 19
2017
Q3 		– Sell
-155,927
Closed -$37.9M – 55
2017
Q2 		$37.9M Buy
155,927
+143,170
+1,122% +$33.6M 12.7% 4
2017
Q1 		$3.05M Sell
12,757
-281,620
-96% -$65.6M 1.22% 25
2016
Q4 		$61.8M Buy
+294,377
New +$61M 29.12% 1
2016
Q2 		– Sell
-76,450
Closed -$20.5M – 89
2016
Q1 		$20.5M Buy
76,450
+34,450
+82% +$9.86M 11.96% 1
2015
Q4 		$13.1M Buy
+42,000
New +$12.5M 6.08% 2

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Argentiere Capital's AGN Position: Q2 2019 in Review

Argentiere Capital sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 26,000 shares — an estimated $3.81M sold.

Argentiere Capital first reported a position in AGN in Q4 2015 and held it in 8 quarters. The position peaked at $61.8M in Q4 2016. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Argentiere Capital reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Argentiere Capital sold 26,000 Allergan plc shares in Q2 2019, an estimated $3.81M.
  • Argentiere Capital first reported a position in Allergan plc in Q4 2015 and held it in 8 quarters.
  • Argentiere Capital's Allergan plc position peaked at $61.8M in Q4 2016.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Argentiere Capital's 13F filing for Q2 2019, filed 14 Aug 2019.